Status:
ENROLLING_BY_INVITATION
Prevalence and Impact of Fatigue in Myasthenic Patients Followed At Clermont-Ferrand University Hospital - "My" Asthenia
Lead Sponsor:
University Hospital, Clermont-Ferrand
Conditions:
Myasthenia Gravis
Eligibility:
All Genders
18+ years
Brief Summary
After identifying myasthenic patients meeting the inclusion criteria, telephone contact with patients to suggest that they participate in the study by responding to various questionnaires composed of ...
Eligibility Criteria
Inclusion
- Adult patients who consulted the neurology department of the Clermont-Ferrand University Hospital between 01/01/2022 and 12/31/2024 in the context of their myasthenia and identified by the BAMARA and PMSI databases of the Clermont-Ferrand University Hospital
- Diagnosis of autoimmune myasthenia gravis based on biological and/or electromyographic criteria
- MGFA class from I to IV
Exclusion
- Patients under guardianship or curatorship
- Non-French speaking patients
- Patients refusing to participate in the study
Key Trial Info
Start Date :
January 31 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06877403
Start Date
January 31 2025
End Date
October 1 2025
Last Update
March 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Clermont-Ferrand
Clermont-Ferrand, France